ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
Eagle Royalties Ltd (CE)

Eagle Royalties Ltd (CE) (ERYTF)

0.0814
0.00
(0.00%)
마감 02 2월 6:00AM

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

주요 통계 및 세부정보

가격
0.0814
매수가
0.00
매도가
0.00
거래량
-
0.00 일간 변동폭 0.00
0.05 52주 범위 0.09
market_cap
전일 종가
0.0814
개장가
-
최근 거래 시간
마지막 거래 시간
재정 규모
-
VWAP
-
평균 볼륨(3m)
13,194
발행 주식
57,060,000
배당수익률
-
주가수익률
-4.26
주당순이익(EPS)
-0.02
매출
-
순이익
-1.07M

Eagle Royalties Ltd (CE) 정보

섹터
Miscellaneous Metal Ores,nec
산업
Miscellaneous Metal Ores,nec
웹사이트
본부
Cranbrook, British Columbia, Can
설립됨
-
Eagle Royalties Ltd (CE) is listed in the Miscellaneous Metal Ores sector of the OTC 시장 with ticker ERYTF. The last closing price for Eagle Royalties (CE) was US$0.08. Over the last year, Eagle Royalties (CE) shares have traded in a share price range of US$ 0.05 to US$ 0.09.

Eagle Royalties (CE) currently has 57,060,000 shares in issue. The market capitalisation of Eagle Royalties (CE) is US$4.64 million. Eagle Royalties (CE) has a price to earnings ratio (PE ratio) of -4.26.

ERYTF 최신 뉴스

No news to show yet.
기간변동변동 %시가고가저가평균 일일 거래량VWAP
10000000CS
4000.08140.08140.081420000.0814CS
120.00648.533333333330.0750.090.05131940.08125248CS
260.00253.168567807350.07890.090.0590860.07875259CS
52-0.0039-4.572098475970.08530.090.0573870.07857156CS
156-0.0239-22.69705603040.10530.10530.0565670.07855241CS
260-0.0239-22.69705603040.10530.10530.0565670.07855241CS

ERYTF - Frequently Asked Questions (FAQ)

What is the current Eagle Royalties (CE) share price?
The current share price of Eagle Royalties (CE) is US$ 0.0814
How many Eagle Royalties (CE) shares are in issue?
Eagle Royalties (CE) has 57,060,000 shares in issue
What is the market cap of Eagle Royalties (CE)?
The market capitalisation of Eagle Royalties (CE) is USD 4.64M
What is the 1 year trading range for Eagle Royalties (CE) share price?
Eagle Royalties (CE) has traded in the range of US$ 0.05 to US$ 0.09 during the past year
What is the PE ratio of Eagle Royalties (CE)?
The price to earnings ratio of Eagle Royalties (CE) is -4.26
What is the reporting currency for Eagle Royalties (CE)?
Eagle Royalties (CE) reports financial results in CAD
What is the latest annual profit for Eagle Royalties (CE)?
The latest annual profit of Eagle Royalties (CE) is CAD -1.07M
What is the registered address of Eagle Royalties (CE)?
The registered address for Eagle Royalties (CE) is SUITE 200, 44-12TH AVENUE SOUTH, CRANBROOK, BRITISH COLUMBIA, V1C 2R7
What is the Eagle Royalties (CE) website address?
The website address for Eagle Royalties (CE) is www.eagleroyalties.com
Which industry sector does Eagle Royalties (CE) operate in?
Eagle Royalties (CE) operates in the MISCELLANEOUS METAL ORES,NEC sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
NXGBNxGen Brands Inc (CE)
US$ 0.003
(299,900.00%)
180.55k
DOCKFBeyond Med Technologies Inc (PK)
US$ 0.055
(54,900.00%)
3.05k
SDCCQSmileDirectClub Inc (CE)
US$ 0.0004
(39,900.00%)
52.05k
LTFDLittlefield Corporation (CE)
US$ 0.1525
(38,025.00%)
240
SGMDSugarmade Inc (CE)
US$ 0.0003
(29,900.00%)
5.94k
RTNBroot9B Holdings Inc (CE)
US$ 0.000001
(-99.97%)
666
THMOThermoGenesis Holdings Inc (CE)
US$ 0.000001
(-99.86%)
250
DOMWFPrime Drink Group Corporation (PK)
US$ 0.0012
(-99.08%)
311.03k
TTCMTautachrome Inc (CE)
US$ 0.000001
(-99.00%)
125.07k
MITJFMint Corporation (CE)
US$ 0.0001
(-99.00%)
12k
HCMCHealthier Choices Management Corporation (PK)
US$ 0.000001
(0.00%)
316.07M
HMBLHUMBL Inc (PK)
US$ 0.0007
(0.00%)
218.85M
GRLFGreen Leaf Innovations Inc (PK)
US$ 0.00015
(-25.00%)
210.68M
RONNRonn Motor Group Inc (PK)
US$ 0.0003
(0.00%)
171.31M
AITXArtificial Intelligence Technology Solutions Inc (PK)
US$ 0.00275
(-1.79%)
134.31M
Kam8 Kam8 3 시간 전
LP just doesn't accept Settlement and go discovery🤞😆🤞, I don't think MMs want discovery so they might accept big money for settlement. 😆😆
NWBO
manibiotech manibiotech 3 시간 전
Agree
Usual few will pump this anyway 
NWBO
manibiotech manibiotech 3 시간 전
lol 
The ceiling has already been put at 40M shares
So dream on
NWBO
Deportes Deportes 3 시간 전
Gfy is that better?
ENZC
Hicham007 Hicham007 3 시간 전
Painful but nothing new...

I have averaged down my portfolio to 6.6$ down from 9.8 and I have now 140k shares and i am ready to increase it to 200k if the SP continues on  dropping.  By now Iova is my only stock market investment so we can say all In...

I am ready finan
IOVA
jammy32 jammy32 3 시간 전
As soon as Trump the genius mentioned Tariffs on pharmaceuticals, this puppy got sick and dropped seven cents. Not good. Shouldn’t Nasrat tell us what this means for Elite. Are we subject to the tariffs where is the API from. Is this a good thing or bad thing. Does nasrat know. Does he
API
rosemountbomber rosemountbomber 3 시간 전
Sleven am I understanding correctly that the Generics get their API from China and Amarin doesn't?
API
BlazingStocks BlazingStocks 3 시간 전
$ILLR Triller CEO Sean Kim joins Yahoo Finance to discuss the fight for TikTok's market share and the outlook for the creator economy:https://x.com/YahooFinance/status/1885453406485033258?t=ldZluPpc4DCzgBoH3GagOA&s=19
ILLR
barnstormer barnstormer 3 시간 전
OK Zadie, the judge only allowed a lousy 40 million shares. Still, consider the following (quick back of the envelope math)

40,000,000 shares / (2752(avg daily volume) x 252 (avg yearly trading days) = 700,104 avg yearly shares traded
40,000,000 shares / 700,104 = 57.14 years
NWBO
BlazingStocks BlazingStocks 3 시간 전
Thank you for sharing this! 
ILLR
VMLG17 VMLG17 3 시간 전
And they’d be stupid if they didn’t settle. If a jury learns that the MMs have continued spoofing after the lawsuit was filed, then damages could be more than any settlement amount, not to mention criminal charges later.
NWBO
Macod Macod 3 시간 전
CHANGE in outstanding shares. First change in over a year. Should be more shares reflected with next update. Those lucky enough to buy privates be on the lookout for your certs

O/S 526,142,269
Restricted 297,633,160
Unrestricted 228,509,109

Increase of 7,6
MRGE
mascale mascale 3 시간 전
Hiru Prepared: Likely for new JORC, 2025, Canadian standard less likely needed. ERM is noted in Hiru basis reporting. "Resource reporting and compliance: we prepare mineral resource reports in accordance with international reporting standards such as NI 43-101, JORC, and CIM. Our experts ensure t
HIRU
stealofadeal stealofadeal 3 시간 전
$ BLTHD The way this is looking with not much on the offer we are going much higher. We are sitting way under the radar. I saw 12.00 the third market maker down on the ask.
BLTHD
nowwhat2 nowwhat2 3 시간 전
scoop um up right at black swan.
XRPUSD
loophole lawyer loophole lawyer 3 시간 전
The 3 most important letters for GTCH…..P,C,T……Checkmate
GTCH
Preciouslife1 Preciouslife1 3 시간 전
https://www.mlb.com/news/mets-counting-on-trade-deadline-additions
jxyzobrien jxyzobrien 3 시간 전
hope you are well
sounds like your company is doing great
say hi when you can
flipper44 flipper44 3 시간 전
The court’s R&R did conclude and preserve NWBO illegal spoofing claims alleged to have been committed by defendants.
NWBO
x993231 x993231 3 시간 전
He does like to make a mountain out of a mole hill, but that is what he gets paid to do.  I have him and many of his alternate ID's on ignore.  He is good at asking, why, why, why.  

X. Yves is good at doing his thing.  Funny remember when Lebby said if I don't perform by the end of t
LWLG
havnagoodtime havnagoodtime 3 시간 전
So, what is the short interest and the FTD report on DPLS? Thanks in advance.
DPLS
MartinLutherKing MartinLutherKing 3 시간 전
E Pluribus Unum brothers The one and only
FDA Approves Phase 1/2 Trial for TransCode's TTX-MC138 in Advanced Tumor Patients
3 June 2024
TransCode Therapeutics, a company dedicated to the advancement of RNA therapeutics in oncology, has received the green light from the U.S. Food
RNAZ
gladeshawk gladeshawk 3 시간 전
AIRI>>>NEWS. Not a penny play but worth a look. HAWK

https://finance.yahoo.com/news/air-industries-group-closes-fiscal-120000021.html
AIRI
MartinLutherKing MartinLutherKing 3 시간 전
E Pluribus Unum brothers The one and only
FDA Approves Phase 1/2 Trial for TransCode's TTX-MC138 in Advanced Tumor Patients
3 June 2024
TransCode Therapeutics, a company dedicated to the advancement of RNA therapeutics in oncology, has received the green light from the U.S. Food
RNAZ
vein vein 3 시간 전
Hey Bubb, I see the cfo received shares , but I don't see the CEO s4??? 
CKPT

최근 히스토리

Delayed Upgrade Clock